All news from Anaesthesiology

Initial Results from Phase I Trial of saRNA Candidate Announced

MiNA Therapeutics, the pioneer in RNA activation (RNAa) therapeutics, today announced preliminary results from its ongoing Phase I study of small activating RNA (saRNA) candidate MTL-CEBPA in advanced liver cancer. In the study, MTL-CEBPA was generally well tolerated in patients with both healthy and impaired liver function and provided evidence of anti-tumor activity. MTL-CEBPA was also found to mediate RNAa activity in white blood cells.

Health Care For Undocumented Immigrants

A new analysis highlights an ironic development in the intertwined issues of immigration and health care – two areas where current and previous administrations differ greatly. Undocumented people in certain states may get more medical help while they are here, it finds, thanks to the current administration's effort to give states more flexibility with their health care spending. And in a reversal of the previous administration's stance, states may find it easier to get that permission.

ARDS: Less-Invasive Treatment Identified

The numbers are grim: Of the 200,000 Americans diagnosed with Acute Respiratory Distress Syndrome (ARDS) each year, 30 to 50% will die. But, clinical researchers at the University of Missouri School of Medicine's Division of Pulmonary, Critical Care, and Environmental Medicine identified a less-invasive treatment option for patients with severely impaired lung function.